Medicover revenue and financials
kr 262.00Change from previous close: +0.77%Absolute change: +kr 2.00
In the fiscal year ended December 2025, Medicover reported revenue of €2.38B (+13.69% year over year). Net income was €77.5M, a net margin of 3.3%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +13.69%
- 2025 vs 2024
- Net income growth
- +364.07%
- 2025 vs 2024
- Net margin
- 3.3%
- 2024: 0.8%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 73.6 | 72.7 | 100 | 57.3 | 87.5 |
| Depreciation and amortization | 55.6 | 54.5 | 54.9 | 54.5 | 50.5 |
| Capital expenditure | -29.7 | -26.0 | -56.9 | -26.8 | -28.1 |
| Investing cash flow | -29.6 | -25.4 | -55.5 | -188 | -32.4 |
| Financing cash flow | -37.0 | -45.7 | -44.7 | 116 | -30.1 |
| Dividends paid | -30.2 | — | — | -22.5 | — |
| Debt issued | 247 | 194 | 225 | 375 | 159 |
| Debt repaid | -207 | -204 | -230 | -192 | -155 |
| Effect of exchange rates | -0.6 | -0.5 | -0.3 | -1.9 | -1.0 |
| Net change in cash | 7.0 | 1.6 | -0.1 | -15.4 | 25.0 |
| Free cash flow | 43.9 | 46.7 | 43.2 | 30.5 | 59.4 |